509077-99-0
509077-99-0 structure
- Name: Ertumaxomab
- Chemical Name: Ertumaxomab
- CAS Number: 509077-99-0
- Molecular Formula:
- Molecular Weight:
- Catalog: Signaling Pathways JAK/STAT Signaling EGFR
- Create Date: 2023-01-16 18:40:11
- Modify Date: 2024-04-08 17:35:11
-
Ertumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breast cancer[1].
| Name | Ertumaxomab |
|---|
| Description | Ertumaxomab (Anti-Human CD22 Recombinant Antibody) is a bispecific antibody targeting HER2/neu and CD3. Ertumaxomab activates Fcγ type I/III-receptors, forming a tri-cell complex among tumour cell, T cell and accessory cell. Ertumaxomab has been used to research breast cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |